PT2976355T - Vacinas contra chlamydia sp - Google Patents
Vacinas contra chlamydia spInfo
- Publication number
- PT2976355T PT2976355T PT147211999T PT14721199T PT2976355T PT 2976355 T PT2976355 T PT 2976355T PT 147211999 T PT147211999 T PT 147211999T PT 14721199 T PT14721199 T PT 14721199T PT 2976355 T PT2976355 T PT 2976355T
- Authority
- PT
- Portugal
- Prior art keywords
- vaccines against
- against chlamydia
- chlamydia
- vaccines
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/118—Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201300155 | 2013-03-18 | ||
| DKPA201300684 | 2013-12-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2976355T true PT2976355T (pt) | 2020-04-02 |
Family
ID=50639248
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT147211999T PT2976355T (pt) | 2013-03-18 | 2014-03-17 | Vacinas contra chlamydia sp |
Country Status (20)
| Country | Link |
|---|---|
| US (4) | US20140275478A1 (enExample) |
| EP (1) | EP2976355B1 (enExample) |
| JP (3) | JP2016514713A (enExample) |
| CN (2) | CN105377879B (enExample) |
| AU (1) | AU2014234765B2 (enExample) |
| BR (1) | BR112015023886B1 (enExample) |
| CA (1) | CA2907199C (enExample) |
| CY (1) | CY1122905T1 (enExample) |
| DK (1) | DK2976355T3 (enExample) |
| ES (1) | ES2781579T3 (enExample) |
| HR (1) | HRP20200511T1 (enExample) |
| HU (1) | HUE048573T2 (enExample) |
| LT (1) | LT2976355T (enExample) |
| PL (1) | PL2976355T3 (enExample) |
| PT (1) | PT2976355T (enExample) |
| RS (1) | RS60135B1 (enExample) |
| RU (1) | RU2723046C2 (enExample) |
| SI (1) | SI2976355T1 (enExample) |
| SM (1) | SMT202000160T1 (enExample) |
| WO (1) | WO2014146663A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6952603B2 (ja) | 2015-02-10 | 2021-10-20 | オハイオ・ステイト・イノベーション・ファウンデーション | クラミジア活性化ｂ細胞プラットフォーム及びその方法 |
| CN104800841B (zh) * | 2015-03-02 | 2019-04-02 | 中国农业科学院兰州兽医研究所 | 牦牛流产衣原体灭活疫苗及其制备方法 |
| CA2980227A1 (en) | 2015-03-24 | 2016-09-29 | Universiteit Gent | A method for the detection of chlamydia suis |
| AU2016349937B2 (en) * | 2015-11-04 | 2021-09-30 | University Of The Sunshine Coast | Chlamydia antigens and uses thereof |
| WO2017083337A1 (en) | 2015-11-10 | 2017-05-18 | Ohio State Innovation Foundation | Methods and compositions related to accelerated humoral affinity |
| NL2019320B1 (en) * | 2017-03-02 | 2018-09-21 | Biosparq B V | Diagnostic method and system for diagnosis |
| CN110603053A (zh) * | 2017-03-23 | 2019-12-20 | 俄亥俄州国家创新基金会 | 重组衣原体活化的b细胞平台及其使用方法 |
| RU2721123C1 (ru) * | 2019-09-26 | 2020-05-18 | федеральное государственное бюджетное учреждение «Национальный исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи» Министерства здравоохранения Российской Федерации | Штамм рекомбинантной псевдоаденовирусной частицы, экспрессирующий химерный ген MBL-CT666 Chlamydia trachomatis, способ его получения, иммуногенная композиция для защиты от урогенитального хламидиоза человека |
| WO2022136508A1 (en) * | 2020-12-23 | 2022-06-30 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Chlamydia vaccine based on targeting momp vs4 antigen to antigen presenting cells |
| CN116854812B (zh) * | 2022-03-23 | 2024-09-24 | 东莞市朋志生物科技有限公司 | 抗沙眼衣原体的抗体、检测沙眼衣原体的试剂和试剂盒 |
| CN115975049A (zh) * | 2022-11-12 | 2023-04-18 | 北京成大天和生物科技有限公司 | 一种沙眼衣原体重组蛋白及其制备方法和应用 |
| AR132053A1 (es) * | 2023-03-02 | 2025-05-21 | Sanofi Pasteur | Composiciones para su uso en el tratamiento de clamidia |
| WO2025104023A1 (en) | 2023-11-13 | 2025-05-22 | Ziphius Nv | MODIFIED ALPHAVIRAL nsP3 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4599230A (en) | 1984-03-09 | 1986-07-08 | Scripps Clinic And Research Foundation | Synthetic hepatitis B virus vaccine including both T cell and B cell determinants |
| US4599231A (en) | 1984-03-09 | 1986-07-08 | Scripps Clinic And Research Foundation | Synthetic hepatitis B virus vaccine including both T cell and B cell determinants |
| US4608251A (en) | 1984-11-09 | 1986-08-26 | Pitman-Moore, Inc. | LHRH analogues useful in stimulating anti-LHRH antibodies and vaccines containing such analogues |
| US4601903A (en) | 1985-05-01 | 1986-07-22 | The United States Of America As Represented By The Department Of Health And Human Services | Vaccine against Neisseria meningitidis Group B serotype 2 invasive disease |
| US5869608A (en) * | 1989-03-17 | 1999-02-09 | The United States Of America As Represented By The Department Of Health And Human Services | Nucleotide and amino acid sequences of the four variable domains of the major outer membrane proteins of Chlamydia trachomatis |
| US5837268A (en) * | 1991-10-16 | 1998-11-17 | University Of Saskatchewan | GnRH-leukotoxin chimeras |
| GB9215780D0 (en) * | 1992-07-24 | 1992-09-09 | Univ London Pharmacy | Peptide compounds |
| DE69322645T2 (de) * | 1992-07-31 | 1999-05-20 | Medeva Holdings B.V., Amsterdam | Expression rekombinanter fusionsproteine in attenuierten bakterien |
| AU669000B2 (en) | 1992-09-18 | 1996-05-23 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Synthetic peptide vaccine for chlamydia trachomatis |
| GB9516293D0 (en) * | 1995-08-09 | 1995-10-11 | Immunova Ltee | Novel peptides and their use as vaccines |
| JP2002512622A (ja) * | 1997-05-06 | 2002-04-23 | バンダービルト ユニバーシティー | クラミジアにより引き起こされる感染の診断および管理のための抗クラミジア剤の組成物 |
| WO2002051430A2 (en) * | 2000-12-22 | 2002-07-04 | Synovis Limited | Methods of modulating toll-related receptor (trr) signaling |
| US7105171B2 (en) | 2002-03-07 | 2006-09-12 | The Regents Of The University Of California | Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia |
| MXPA05013260A (es) * | 2003-06-26 | 2006-03-09 | Chiron Corp | Composiciones inmunogenicas para chlamydia trachomatis. |
| EP2269636A3 (en) * | 2004-10-25 | 2011-04-06 | Statens Serum Institut | Chlamydia trachomatis antigens for vaccine and diagnostic use |
| WO2006125076A2 (en) * | 2005-05-18 | 2006-11-23 | Trinity Biosystems, Inc. | Methods and compositions for immunizing against chlamydia infection |
| TW201012929A (en) * | 2008-09-29 | 2010-04-01 | Univ Nat Pingtung Sci & Tech | A hybridoma cell line producing monoclonal antibodies against chalmydophila aborts |
| EP2413959A4 (en) * | 2009-01-29 | 2013-06-19 | British Columbia Cancer Agency | CHLAMYDIA-ANTIGENE COMPREHENSIVE COMPOSITIONS |
| US8735543B2 (en) * | 2010-05-28 | 2014-05-27 | Spixia Biotechnology Ab | Chimeric MOMP antigen |
| US9308248B2 (en) * | 2011-06-17 | 2016-04-12 | Universiteit Gent | Vaccines for Chlamydia |
-
2014
- 2014-03-17 US US14/216,403 patent/US20140275478A1/en not_active Abandoned
- 2014-03-17 CN CN201480026477.5A patent/CN105377879B/zh active Active
- 2014-03-17 SI SI201431541T patent/SI2976355T1/sl unknown
- 2014-03-17 CN CN202110407442.8A patent/CN113185587A/zh active Pending
- 2014-03-17 HU HUE14721199A patent/HUE048573T2/hu unknown
- 2014-03-17 SM SM20200160T patent/SMT202000160T1/it unknown
- 2014-03-17 EP EP14721199.9A patent/EP2976355B1/en active Active
- 2014-03-17 HR HRP20200511TT patent/HRP20200511T1/hr unknown
- 2014-03-17 CA CA2907199A patent/CA2907199C/en active Active
- 2014-03-17 WO PCT/DK2014/000015 patent/WO2014146663A1/en not_active Ceased
- 2014-03-17 RS RS20200360A patent/RS60135B1/sr unknown
- 2014-03-17 LT LTEP14721199.9T patent/LT2976355T/lt unknown
- 2014-03-17 DK DK14721199.9T patent/DK2976355T3/da active
- 2014-03-17 PT PT147211999T patent/PT2976355T/pt unknown
- 2014-03-17 JP JP2016503549A patent/JP2016514713A/ja active Pending
- 2014-03-17 RU RU2015141214A patent/RU2723046C2/ru active
- 2014-03-17 PL PL14721199T patent/PL2976355T3/pl unknown
- 2014-03-17 AU AU2014234765A patent/AU2014234765B2/en active Active
- 2014-03-17 ES ES14721199T patent/ES2781579T3/es active Active
- 2014-03-17 BR BR112015023886-6A patent/BR112015023886B1/pt active IP Right Grant
-
2018
- 2018-04-18 US US15/956,731 patent/US10925954B2/en active Active - Reinstated
-
2019
- 2019-03-20 JP JP2019052389A patent/JP7510142B2/ja active Active
-
2020
- 2020-03-27 CY CY20201100285T patent/CY1122905T1/el unknown
-
2021
- 2021-01-22 US US17/155,264 patent/US20210205433A1/en active Pending
- 2021-09-13 JP JP2021148819A patent/JP7506930B2/ja active Active
-
2025
- 2025-05-02 US US19/197,254 patent/US20250255951A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT2976355T (pt) | Vacinas contra chlamydia sp | |
| EP3065716C0 (en) | FORMULATIONS | |
| UA27432S (uk) | Інтерфейс графічний | |
| UA27427S (uk) | Інтерфейс графічний | |
| UA27423S (uk) | Інтерфейс графічний | |
| UA27429S (uk) | Інтерфейс графічний | |
| UA27422S (uk) | Інтерфейс графічний | |
| UA27435S (uk) | Інтерфейс графічний | |
| UA27425S (uk) | Інтерфейс графічний | |
| UA27421S (uk) | Інтерфейс графічний | |
| UA27417S (uk) | Інтерфейс графічний | |
| UA27439S (uk) | Інтерфейс графічний | |
| UA27419S (uk) | Інтерфейс графічний | |
| UA27418S (uk) | Інтерфейс графічний | |
| UA28372S (uk) | Пристрій для випрямлення волосся | |
| UA27424S (uk) | Інтерфейс графічний | |
| UA27431S (uk) | Інтерфейс графічний | |
| DE112014004527A5 (de) | Aktor | |
| EP2958994A4 (en) | Vaccine composition | |
| HRP20181376T1 (hr) | Poboljšana cjepiva protiv poksvirusa | |
| EP2961397A4 (en) | TRANSDERMAL FORMULATIONS | |
| EP2977381A4 (en) | TERPENOIDDERIVAT | |
| DK2958935T3 (da) | Vaccine | |
| BR112016000723A2 (pt) | Atuador | |
| DOS2013000229S (es) | Dulces |